Showing results (61-70 of 238) with videos related to

Sort By:
Pageof 24
Transplantation Direct|November 6, 2023
A Clinical Model to Predict the Occurrence of Select High-risk Infections in the First Year Following Heart TransplantationWhitney A Perry, Jennifer K Chow, Jason Nelson, et al.
Stroke|April 17, 2004
In acute ischemic stroke, are asymptomatic intracranial hemorrhages clinically innocuous?David M Kent, Judith Hinchey, Lori Lyn Price, et al.
The American Journal of Managed Care|April 17, 2015
Multiple chronic conditions in type 2 diabetes mellitus: prevalence and consequencesPei-Jung Lin, David M Kent, Aaron Winn, et al.
International Journal of Epidemiology|November 29, 2025
Diverging conclusions from risk difference and difference in restricted mean survival time in quantifying absolute treatment effect heterogeneityCarolien C H M Maas, David M Kent, Avinash G Dinmohamed, et al.
The American Journal of Bioethics : AJOB|November 26, 2003
Testing therapies less effective than the best current standard: ethical beliefs in an international sample of researchersDavid M Kent, Makaya Mwamburi, Richard A Cash, et al.
AIDS Patient Care and Stds|April 10, 2015
Myocardial Infarction, Stroke, and Mortality in cART-Treated HIV Patients on StatinsMartin Krsak, David M Kent, Norma Terrin, et al.
BMC Medical Research Methodology|March 28, 2023
Estimating individualized treatment effects from randomized controlled trials: a simulation study to compare risk-based approachesAlexandros Rekkas, Peter R Rijnbeek, David M Kent, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|April 12, 2017
Understanding the Value of Individualized Information: The Impact of Poor Calibration or Discrimination in Outcome Prediction ModelsNatalia Olchanski, Joshua T Cohen, Peter J Neumann, et al.
JAMA Network Open|July 22, 2025
Predictive Modeling of Heterogeneous Treatment Effects in RCTs: A Scoping ReviewJoe V Selby, Carolien C H M Maas, Bruce H Fireman, et al.
Pageof 24